| Literature DB >> 23208469 |
Ramzi A Mothana1, Nawal M Al-Musayeib, An Matheeussen, Paul Cos, Louis Maes.
Abstract
Malaria, leishmaniasis and human African trypanosomiasis continue to be major public health problems in need of new and more effective drugs. The aim of this study was to evaluate in vitro antiprotozoal activity of twenty endemic medicinal plants collected from the island of Soqotra in the Indian Ocean. The plant materials were extracted with methanol and tested for antiplasmodial activity against erythrocytic schizonts of Plasmodium falciparum, for antileishmanial activity against intracellular amastigotes of Leishmania infantum and for antitrypanosomal activity against intracellular amastigotes of Trypanosoma cruzi and free trypomastigotes of T. brucei. To assess selectivity, cytotoxicity was determined against MRC-5 fibroblasts. Selective activity was obtained for Punica protopunica against Plasmodium (IC₅₀ 2.2 µg/mL) while Eureiandra balfourii and Hypoestes pubescens displayed activity against the three kinetoplastid parasites (IC₅₀ < 10 µg/mL). Acridocarpus socotranus showed activity against T. brucei and T. cruzi (IC₅₀ 3.5 and 8.4 µg/mL). Ballochia atrovirgata, Dendrosicycos socotrana, Dracaena cinnabari and Euphorbia socotrana displayed non-specific inhibition of the parasites related to high cytotoxicity.Entities:
Mesh:
Substances:
Year: 2012 PMID: 23208469 PMCID: PMC6268263 DOI: 10.3390/molecules171214349
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
List of plants from the island of Soqotra that were screened in the study for antiprotozoal potential.
| Plant species | Voucher specimen no. | Family |
| Traditional uses a |
|---|---|---|---|---|
| Mo-Sq28 | Mimosaceae | L | As a paste around the breast for women with mastitis | |
| Mo-Sq16 | Malpighiaceae | L,S | Headaches, paralysis and muscle or tendon pain | |
| Mo-Sq9 | Aloaceae | R | Eye and stomach problems, constipation and malaria | |
| Mo-Sq15 | Acanthaceae | S, L | Unknown | |
| Mo-Sq24 | Burseraceae | B | Common cold, bronchitis, asthma and rheumatism | |
| Mo-Sq23 | Burseraceae | B | Antiseptic, diarrhea, dysentery and emesis | |
| Mo-Sq4 | Euphorbiaceae | L, Fr | Wounds, anthelmintic | |
| SP-A015 | Cucurbitaceae | L, S | Urinary retention, cystitis, diabetes and problem with liver | |
| SP-M122 | Moraceae | L, S | Flatulence, indigestion and skin diseases | |
| SP-D225 | Agavaceae | Re | Swellings, inflammations, sores, rashes, itching, stomach pain, haemostatic and oral health | |
| Mo-Sq1 | Ebenaceae | R | For oral care, tooth ache, fungal diseases, sores, wounds and abscesses | |
| Mo-Sq5 | Euphorbiaceae | L | For skin diseases and wounds | |
| Mo-Sq3 | Cucurbitaceae | L | Unknown | |
| Mo-Sq30 | Malvaceae | L, R | For snake bite and fever in children | |
| Mo-Sq12 | Acanthaceae | L | Fungal skin diseases and scabies | |
| Mo-Sq20 | Solanaceae | L, S | For stomach ailments and encourage the wound healing | |
| Mo-Sq7 | Capparaceae | L | To treat fever, aches and general malaise | |
| SP-D223 | Punicaceae | Fr | Anthelmintic, peptic ulcers, dysentery, diarrhea, sores and wounds | |
| Mo-Sq18 | Anacardiaceae | Fr, L | To treat anorexia, general tonic and for painful joints | |
| Mo-Sq22 | Labiatae | Fl, L | As flavoring agent and for indigestion |
* endemic plant, B: Bark, Fl: Flower, L: Leaves, R: Roots or rhizomes, Re: Resin, S: Stems, Fr: Fruits; a Most of the information of traditional use has been taken from [21] and native people.
Antiprotozoal activity and cytotoxicity (IC50 µg/mL) of the methanolic extracts of the investigated plants.
| Plant species |
|
|
|
| MRC-5 | ||||
|---|---|---|---|---|---|---|---|---|---|
| IC50 | SI | IC50 | SI | IC50 | SI | IC50 | SI | IC50 | |
|
| >64.0 | >64.0 | 27.0 ± 4.7 | 8.3± 1.7 | 3.4 | 28.1 ± 2.6 | |||
|
| 21.6 ± 4.3 | 32.5 ± 6.2 | 8.4 ± 1.3 | >7.6 | 3.5 ± 0.9 | >18 | >64.0 | ||
|
| 60.6 ± 7.8 | >64.0 | >64.0 | 31.7 ± 4.7 | >64.0 | ||||
|
| 2.9 ± 1.3 | <1 | 6.0 ± 1.8 | <1 | 0.6 ± 0.2 | 3.4 | 2.1 ± 0.8 | 1.0 | 2.1 ± 0.6 |
|
| >64.0 | 50.8 ± 7.9 | 8.3 ± 2.4 | 3.9 | 9.3 ± 2.7 | 3.5 | 32.2 ± 5.9 | ||
|
| 64.0 | >64.0 | >64.0 | >64.0 | >64.0 | ||||
|
| >64.0 | >64.0 | >64.0 | >64.0 | >64.0 | ||||
|
| 8.4 ± 2.1 | <1 | <0.25 | <1 | 0.6 ± 0.1 | 1.1 | 7.3 ± 2.1 | <1 | 0.7 ± 0.3 |
|
| >64.0 | >64.0 | >64.0 | 40.3 ± 6.3 | >64.0 | ||||
|
| 2.1 ± 0.9 | 3.6 | 8.1 ± 1.7 | <1 | 4.1 ± 1.3 | 1.9 | 8.0 ± 1.8 | <1 | 7.7 ± 2.0 |
|
| 37.5 ± 4.7 | >64.0 | 22.5 ± 4.7 | 33.1 ± 5.3 | 27.5 ± 3.6 | ||||
|
| 10.1 ± 1.8 | 7.5 ± 2.4 | 1.2 | 8.1 ± 1.6 | 1.1 | 1.9 ± 0.5 | 4.7 | 8.9 ± 1.2 | |
|
| 21.2 ± 2.9 | 6.0 ± 0.8 | 3.5 | 8.3 ± 1.3 | 2.5 | 8.1 ± 2.2 | 2.6 | 20.9 ± 2.8 | |
|
| 29.9 ± 4.7 | 32.5 ± 5.3 | 29.1 ± 4.6 | 8.2 ± 1.7 | 3.3 | 26.8 ± 3.8 | |||
|
| 4.3 ± 3.1 | 7.6 | 7.5 ± 2.3 | 4.4 | 7.4 ± 2.1 | 4.4 | 2.0 ± 0.9 | 16.3 | 32.7 ± 4.2 |
|
| 35.2 ± 6.2 | >64.0 | 23.8 ± 5.8 | 8.2 ± 2.2 | 2. 6 | 20.9 ± 2.6 | |||
|
| >64.0 | >64.0 | 31.3 ± 6.3 | 33.7 ± 3.4 | >64.0 | ||||
|
| 2.2 ± 0.8 | 13.3 | 30.1 ± 6.8 | 32.9 ± 5.2 | 8.9 ± 1.9 | 3.3 | 29.5 ± 3.7 | ||
|
| 37.1 ± 4.9 | >64.0 | 30.5 ± 4.3 | 34.0 ± 4.5 | 53.2 ± 9.3 | ||||
|
| 41.6 ± 6.3 | >64.0 | 31.7± 6.1 | 7.9 ± 2.2 | >8 | >64.0 | |||
| Chloroquine | 0.3 ± 0.1 | >213 | - | - | >64.0 | ||||
| Miltefosine | - | 3.32 ± 0.7 | >19 | - | >64.0 | ||||
| Benznidazole | - | - | 2.2 ± 0.5 | >29 | >64.0 | ||||
| Suramin | - | - | - | 0.03 ± 0.02 | >2133 | >64.0 | |||
| Tamoxifen | - | - | - | 11.0 ± 2.3 | |||||
IC50 values of reference drugs are expressed in µM; SI: selectivity index (ratio of the IC50 value of the cytotoxicity against MRC-5 to the IC50 value of the antiparasitic activity): only listed for the extracts that complied with the activity criterion IC50 < 10 µg/mL.